1.42 USD
▼-0.02-1.28%
盘后 1.70 0.00%
2026-09-16
市值
$9.95M
市盈率
—
EPS
-4.77
股息率
—
52 周区间
0.62 – 12.40
成交量
96.73K
Beta
1.67
目标价
12.50
52W 低 0.6252W 高 12.40
价格走势
公司简介
FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company’s product pipeline includes CYWC628 which has completed pre-clinical trial for the treatment of wound healing; CYMS101 which has completed Phase 1 trial for the treatment of multiple sclerosis; CybroCell for the treatment of degenerative disc disease; and CYPS317 for the treatment of psoriasis. It also develops early-stage research products, includi...